Inger Johansson

5PUBLICATIONS
15CO-AUTHORS
PharmacogenomicsBehavioural geneticsGene expression (incl. microarray and other genome-wide approaches)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 22, 2025
Improved Prediction of CYP2D6 Catalyzed Drug Metabolism by Taking Variant Substrate Specificities and Novel Polymorphic Haplotypes into Account.

Inger Johansson, Emmanouella M Xanthopoulou, Yitian Zhou

|Sep 16, 2022
Response to Rowland et al. and Achour et al.

Chris S Pridgeon, Inger Johansson, Magnus Ingelman-Sundberg

|Jun 29, 2022
Liquid Biopsies or Therapeutic Drug Monitoring for CYP Activity Profile Determination.

Chris S Pridgeon, Inger Johansson, Magnus Ingelman-Sundberg

|Mar 07, 2022
The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients.

Hasan Çağın Lenk, Katharina Klöditz, Inger Johansson

Pageof 1